Global Biobetters Market Analysis to 2034 by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region, Featuring Exhaustive Profiles of the Top 10+ Players
09 avr. 2024 11h54 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region" report has been...
Global Biosimilars Market Size, Share & Trends Analysis 2023 - 2030: Unlocking Affordable Therapies - The Increasing Role of Biosimilars in Patient Care
16 août 2023 09h13 HE
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By...
BiondVax CEO Issues Letter to Shareholders
30 déc. 2022 07h30 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
Insights on the Biosimilars Global Market to 2025 - Featuring Amgen, Cipla and Pfizer Among Others
15 juin 2021 06h18 HE
|
Research and Markets
Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market should reach $60.1...